glutathione s-transferase gst 6 SDS-PAGE analysis of glutathione S-transferase

98 g/wk (%) 60 (24.6) 157 (18.6) .041 Current smoker (%) 49 (20.7) 168 (20.4) .936 Cardiovascular disease (%) 45 (18.2) 119 (13.8) .082 Diabetic retinopathy (%) 44 (23.3) 128 (19.6) .265 Systolic BP, mm Hg 130.1 12.6 128.4 12.3 .047 Diastolic BP, mm Hg 78.010.1 76.99.4 .090 Hypertension (%) 179 (72.5) 574 (66.7) .085 Anemia (%) 48 (19.4) 117 (13.6) .022 Neuropathy (%) 67 (28.0) 179 (21.4) .031 Fasting glucose, mg/dL 139.4 36.6 138.7 37.3 .791 Hemoglobin A1c (%) 7.1 0.9 7.2 1.0 .167 HOMA-IR 1.1 0.9 1.2 2.5 .763 Hemoglobin, g/dL 13.6 1.6 13.8 1.7 .053 MCV, fL 90.44.7 91.7 29.9 .504 Total cholesterol, mg/dL 144.5 27.0 146.5 25.7 .285 Triglyceride, mg/dL 138.8 70.8 137.5 70.6 .800 HDL-cholesterol, mg/dL 45.6 10.5 46.0 10.8 .612 LDL-cholesterol, mg/dL 76.4 24.3 77.6 21.9 .466 AST, IU/L 25.4 10.7 28.2 12.7 .001 ALT, IU/L 23.4 13.4 28.2 16.5 2

Simultaneously, silybin improves endothelial dysfunctiona critical link in the onset of inflammationby lowering asymmetric dimethylarginine (ADMA) levels, thereby reversing nitric oxide synthase inhibition and increasing the bioavailability of NO, which possesses anti-inflammatory and vasodilatory functions

Germany - Germany is a major hub for peptide therapeutics in Europe, with strong government-backed funding for translational research and clinical trials

Main ingredients: Glutathione, Vitamin C & E, Kojic acid, Glycolic Acid

Stage IV occurs after 96 hours following the recovery from stage III